NET PROFIT (x1000 DKK)
EMPLOYEES
Active Biotech AB (publ)
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
136
|
160
|
358 |
| Earnings before taxes |
-25,587
|
-30,763
|
-39,006 |
| EBITDA |
-25,875
|
-31,222
|
-38,681 |
| Total assets |
28,046
|
29,585
|
34,083 |
| Current assets |
25,465
|
26,001
|
29,482 |
| Current liabilities |
5,785
|
6,972
|
8,060 |
| Equity capital |
21,265
|
20,598
|
23,061 |
| - share capital |
4,126
|
1,255
|
914 |
| Employees (average) |
7
|
8
|
9 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
75.8%
|
69.6%
|
67.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-90.7%
|
-103.4%
|
-113.4% |
| Current ratio |
440.2%
|
372.9%
|
365.8% |
| Return on equity (ROE) |
-120.3%
|
-149.3%
|
-169.1% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
-1
|
-1
|
1 |
| Chg. No. of employees % |
-13%
|
-11%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.